Keywords: Roche, Avastin, Metastatic breast cancer, UK, NICE

NICE draft guidance continues negative on Roche's Avastin for metastatic breast cancer

Article | 06 July 2012

Print This

Final draft guidance published today (July 6) by the UK’s drugs watchdog the National Institute for Health and Clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in